Increased CD36 Expression Signals Monocyte Activation Among Patients With Type 2 Diabetes
Article Information
vol. 33 no. 9 2065-2067
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 9, 2010
- Accepted June 9, 2010
- Published in print August 30, 2010.
- Published online ahead of print June 14, 2010.
Article Versions
- Previous version (June 14, 2010 - 19:39).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2010 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
Author Information
- Yijuan Sun, MD, MS1,
- Marina Scavini, MD2,
- Robert A. Orlando, PHD3,
- Glen H. Murata, MD1,
- Karen S. Servilla, MD1,
- Antonios H. Tzamaloukas, MD1,
- Ronald Schrader, PHD4,
- Edward J. Bedrick, PHD2,
- Mark R. Burge, MD2,
- Nada A. Abumrad, PHD5 and
- Philip G. Zager, MD2
- 1Department of Medicine, Veteran Affairs Medical Center, Albuquerque, New Mexico;
- 2Department of Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico;
- 3Department of Biochemistry and Molecular Biology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico;
- 4Clinical Translational Sciences Center, University of New Mexico Health Sciences Center, Albuquerque, New Mexico;
- 5Department of Medicine, Center for Human Nutrition, Washington University, St. Louis, Missouri.
- Corresponding author: Philip G. Zager, pzag{at}unm.edu.
Statistics from Altmetric.com
Article usage
In this Issue
September 2010, 33(9)
Increased CD36 Expression Signals Monocyte Activation Among Patients With Type 2 Diabetes
